GENEVA (AP) — Swiss biotech company Roche says sales grew 5 percent in the first nine months of the year, crediting new product launches and citing double-digit growth in the pharmaceuticals division in the U.S. market. The Basel-based drugs and diagnostics group expressed confidence about meeting full-year targets and pointed to recent regulatory approvals in the European Union. Overall, sales rose to 39.4 billion Swiss francs ($40.2 billion) in the period, from 37.5 billion a year earlier.